Skip to content
Screener

Mesa Laboratories MLAB Q1 2026 earnings

Reported August 5, 2025 · Before market open

Revenue$59.5MMiss by $857.0K
EPS$2.32Miss by $0.14
Revenue estimate$60.4M
EPS estimate$2.46

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$61.6M
EPS estimate$1.59

Financials

Q1 2026

Income statement

See full
Revenue$59.5M+2.4%
Net income$4.7M+40.0%

Balance sheet

See full
Cash & equivalents$21.3M-25.3%
Total debt$166.7M+130%
Total equity$172.5M+14.4%
Total assets$435.7M-1.0%

Cash flow

See full
Operating cash flow$1.9M-82.4%
CapEx$1.0M+13.2%
Free cash flow$884.0K-91.0%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$537.85M+14.9%
Enterprise value$683.29M+33.4%
P/S2.2×+0.1×

Profitability

See full
Net margin-0.3%-0.1pp
FCF margin13.9%-4.8pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity1×+0.5×
Current ratio0.7×-1.3×

Segments

By geography

See full
US$27.6M+2.9%
Other$26.5M+6.9%
CN$5.4M-17.2%

By segment

See full
Biopharmaceutical Development$11.5M-4.3%
Clinical Genomics$10.3M-9.7%

By product

See full
Consumables$35.8M+8.4%
Hardware And Software$12.6M-10.7%

FAQ

When did Mesa Laboratories report Q1 2026 earnings?
Mesa Laboratories (MLAB) reported Q1 2026 earnings on August 5, 2025 before market open.
What were Mesa Laboratories's Q1 2026 revenue and EPS?
Mesa Laboratories reported revenue of $59.5M and eps of $2.32 for Q1 2026.
Did Mesa Laboratories beat estimates in Q1 2026?
Revenue missed the consensus estimate of $60.4M by $857.0K. EPS missed the consensus estimate of $2.46 by $0.14.
How did Mesa Laboratories's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.4% from $58.2M a year earlier and eps declined 18.0% from $2.83.
Where can I find Mesa Laboratories's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001437749-25-024714) and the 10-Q periodic report (0001437749-25-024715) directly on SEC EDGAR. The filing index links above go to sec.gov.